Revenue (Quarterly) Chart

View Revenue (Quarterly) for MURGY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 21.68B
March 31, 2026 20.02B
December 31, 2025 20.00B
September 30, 2025 20.87B
June 30, 2025 19.86B
March 31, 2025 19.10B
December 31, 2024 18.29B
September 30, 2024 19.55B
June 30, 2024 18.87B
March 31, 2024 19.13B
December 31, 2023 18.69B
September 30, 2023 17.73B
June 30, 2023 17.28B
March 31, 2023 17.85B
December 31, 2022 17.51B
September 30, 2022 17.01B
June 30, 2022 16.72B
March 31, 2022 17.68B
December 31, 2021 20.78B
September 30, 2021 20.99B
June 30, 2021 23.12B
March 31, 2021 20.04B
December 31, 2020 21.35B
September 30, 2020 19.21B
June 30, 2020 18.46B
Date Value
March 31, 2020 15.30B
December 31, 2019 18.51B
September 30, 2019 18.45B
June 30, 2019 17.53B
March 31, 2019 18.22B
December 31, 2018 15.94B
September 30, 2018 15.38B
June 30, 2018 15.38B
March 31, 2018 16.22B
December 31, 2017 16.71B
September 30, 2017 15.90B
June 30, 2017 15.21B
March 31, 2017 15.24B
December 31, 2016 15.30B
September 30, 2016 15.54B
June 30, 2016 16.53B
March 31, 2016 14.21B
December 31, 2015 15.71B
September 30, 2015 15.08B
June 30, 2015 16.41B
March 31, 2015 16.18B
December 31, 2014 18.46B
September 30, 2014 18.01B
June 30, 2014 20.42B
March 31, 2014 20.00B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Hannover Rück SE 8.322B
Allianz SE 50.48B
Arch Capital Group Ltd. 4.472B
Greenlight Capital Re Ltd. 160.88M
Sampo Oyj 3.671B